134 related articles for article (PubMed ID: 36425573)
21. [Study on the pharmacognosy of traditional Chinese medicine tubeimu].
Xie Z; Liu X; Cao L
Zhong Yao Cai; 1998 Nov; 21(11):548-51. PubMed ID: 12569818
[TBL] [Abstract][Full Text] [Related]
22. Potent anti-tumorigenic effect of tubeimoside 1 isolated from the bulb of Bolbostemma paniculatum (Maxim) Franquet.
Yu LJ; Ma RD; Wang YQ; Nishino H; Takayasu J; He WZ; Chang M; Zhen J; Liu WS; Fan SX
Int J Cancer; 1992 Feb; 50(4):635-8. PubMed ID: 1537629
[TBL] [Abstract][Full Text] [Related]
23. The potential role of tubeimosides in cancer prevention and treatment.
Islam MS; Wang C; Zheng J; Paudyal N; Zhu Y; Sun H
Eur J Med Chem; 2019 Jan; 162():109-121. PubMed ID: 30439592
[TBL] [Abstract][Full Text] [Related]
24. Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities.
Zhang J; Yang Z; Jia X; Li X; Wang X; Rong H; Liang Y; Zeng W; Jia W; Ma X
Front Pharmacol; 2022; 13():1080645. PubMed ID: 36479197
[TBL] [Abstract][Full Text] [Related]
25. Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Leineweber CG; Rabehl M; Pietzner A; Rohwer N; Rothe M; Pech M; Sangro B; Sharma R; Verslype C; Basu B; Sengel C; Ricke J; Schebb NH; Weylandt KH; Benckert J
Front Pharmacol; 2023; 14():1354581. PubMed ID: 38273836
[TBL] [Abstract][Full Text] [Related]
26. Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress.
Zhang Q; Chen W; Lv X; Weng Q; Chen M; Cui R; Liang G; Ji J
Front Pharmacol; 2022; 13():806724. PubMed ID: 35899109
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effects of Smilax glabra and Bolbostemma paniculatum on rheumatoid arthritis using a rat paw edema model.
Bao Y; Li H; Li QY; Li Y; Li F; Zhang CF; Wang CZ; Yuan CS
Biomed Pharmacother; 2018 Dec; 108():309-315. PubMed ID: 30227323
[TBL] [Abstract][Full Text] [Related]
28. Corrigendum: Exploring the Mechanism of Total Flavonoids of Drynariae Rhizoma to Improve Large Bone Defects by Network Pharmacology and Experimental Assessment.
Sun W; Li M; Xie L; Mai Z; Zhang Y; Luo L; Yan Z; Li Z; Dong H; Huang F; Shen Z; Jiang Z
Front Pharmacol; 2021; 12():739503. PubMed ID: 34366874
[TBL] [Abstract][Full Text] [Related]
29. Corrigendum: COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis.
Chu Z; Shi X; Chen G; He X; Qian Y; Wang H; Tao L; Liu Y; Jiang W; Chen J
Front Pharmacol; 2021; 12():831941. PubMed ID: 35069227
[TBL] [Abstract][Full Text] [Related]
30. Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology.
Liu Y; Tan Y; Huang J; Wu C; Fan X; Stalin A; Lu S; Wang H; Zhang J; Zhang F; Wu Z; Li B; Huang Z; Chen M; Cheng G; Mou Y; Wu J
Front Pharmacol; 2023; 14():1243304. PubMed ID: 37564177
[TBL] [Abstract][Full Text] [Related]
31. Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction.
Yan H; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
Front Pharmacol; 2021; 12():808424. PubMed ID: 35126142
[TBL] [Abstract][Full Text] [Related]
32. Corrigendum: Wuzi Yanzong pill-Based on network pharmacology and
Chen WQ; Ding CF; Yu J; Wang CY; Wan LY; Hu HM; Ma JX
Front Pharmacol; 2022; 13():1129448. PubMed ID: 36712666
[TBL] [Abstract][Full Text] [Related]
33. Corrigendum: Dosage Modification of Traditional Chinese Medicine Prescriptions: An Analysis of Two Randomized Controlled Trials.
Zhou R; Zheng Y; An X; Jin D; Lian F; Tong X
Front Pharmacol; 2022; 13():844063. PubMed ID: 35370656
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Analgesic and Anti-Inflammatory Effects of Xiaoyuningkun Decoction with Cynanchum Paniculatum and Fukeqianjin in a Mouse Model of Pelvic Inflammatory Disease.
Tang B; Wu K; Meng Q; Wang F
Med Sci Monit; 2019 Nov; 25():9094-9102. PubMed ID: 31784502
[TBL] [Abstract][Full Text] [Related]
35. Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells.
Hu B; An HM; Yan X; Zheng JL; Huang XW; Li M
BMC Complement Altern Med; 2019 Mar; 19(1):67. PubMed ID: 30876428
[TBL] [Abstract][Full Text] [Related]
36. Corrigendum: Network pharmacology-based prediction of active compounds in Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support
Tang D; Wang RY; Sun KW; Wu Y; Ding L; Mo Y
Front Pharmacol; 2022; 13():1105804. PubMed ID: 36532739
[TBL] [Abstract][Full Text] [Related]
37. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.
Yin X; Li J; Hao Z; Ding R; Qiao Y
Front Cell Infect Microbiol; 2022; 12():964469. PubMed ID: 36046748
[TBL] [Abstract][Full Text] [Related]
38. [Cell cycle arrest and apoptosis induced by tubeimoside in HeLa cell].
Yang P; Yu TX; Ma RD; Yu LJ; Su WM; Shao HY; Liao MN; Huang LZ
Ai Zheng; 2002 Apr; 21(4):346-50. PubMed ID: 12452008
[TBL] [Abstract][Full Text] [Related]
39. Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer's disease.
Luo Y; Li D; Liao Y; Cai C; Wu Q; Ke H; Liu X; Li H; Hong H; Xu Y; Wang Q; Fang J; Fang S
Front Pharmacol; 2023; 14():1239060. PubMed ID: 37869758
[TBL] [Abstract][Full Text] [Related]
40. Anti-Deinagkistrodon acutus venom properties of ethanolic root extract from Cynanchum paniculatum (Bunge) kitag and its GC-MS analysis.
Xiong Y; Li B; Huang D; He Q; Yu X
J Ethnopharmacol; 2018 Oct; 225():189-197. PubMed ID: 30033377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
